The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: Results from the observational study GEM1801.
 
Pablo Ayala de Miguel
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi
 
Miguel-Angel Berciano-Guerrero
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Eisai; MSD; Novartis; Pierre Fabre
Research Funding - Novartis
 
Eva Muñoz-Couselo
Honoraria - BMS; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; MSD; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Bristol-Myers Squibb/Celgene; MSD; Novartis; Pierre Fabre; Sanofi
 
Jose Luis Manzano
No Relationships to Disclose
 
Pablo CEREZUELA Fuentes
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi; Sun Pharma
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi; Sun Pharma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
AINARA SORIA RIVAS
No Relationships to Disclose
 
Almudena García Castaño
No Relationships to Disclose
 
Guillermo Crespo
No Relationships to Disclose
 
Teresa Puértolas
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore; Novartis; Seagen
Travel, Accommodations, Expenses - MSD; Novartis; Pierre Fabre
 
Carlos Aguado De La Rosa
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; Sanofi
Research Funding - AstraZeneca; Mirati Therapeutics; MSD
Travel, Accommodations, Expenses - Novartis; Pierre Fabre; Roche
 
Lourdes Gutiérrez Sanz
No Relationships to Disclose
 
Rafael López Castro
Honoraria - AstraZeneca Spain; Bristol-Myers Squibb/Celgene; Roche; Takeda
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim; MSD Oncology; Novartis; Roche
Research Funding - MSD Oncology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD; Novartis; Roche; Takeda
 
Enrique Espinosa
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Maria Jose Lecumberri
No Relationships to Disclose
 
Margarita Majem
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Helsinn Therapeutics; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Roche
 
Javier Medina Martinez
No Relationships to Disclose
 
Lorena Bellido
Honoraria - AstraZeneca Spain
Consulting or Advisory Role - Sanofi
 
Luis Antonio Fernandez
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - Novartis; Pfizer
 
Salvador Martin-Algarra
Consulting or Advisory Role - MSD Oncology
Speakers' Bureau - AstraZeneca (I); Bristol-Myers Squibb; MSD Oncology; PharmaMar; Roche (I)
Travel, Accommodations, Expenses - MSD (I); Roche (I)
 
Ivan Marquez-Rodas
Consulting or Advisory Role - Amgen; AstraZeneca; Bioncotech; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; MSD; Novartis; Pierre Fabre; Regeneron; Roche; Sanofi; Sun Pharma
Travel, Accommodations, Expenses - Bioncotech; Bristol-Myers Squibb; MSD; Pierre Fabre; Roche; Sun Pharma